Placemark Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Placemark Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$5.91M	Buy	102,833 +4,999	+5%	+$279K	0.1%	246
2014 Q3	$5.26M	Buy	97,834 +35,209	+56%	+$1.87M	0.1%	258
2014 Q2	$3.28M	Buy	62,625 +13,333	+27%	+$681K	0.06%	391
2014 Q1	$2.6M	Sell	49,292 -5,436	-10%	-$251K	0.05%	440
2013 Q4	$2.19M	Buy	54,728 +15,694	+40%	+$618K	0.04%	527
2013 Q3	$1.47M	Sell	39,034 -9,632	-20%	-$376K	0.03%	633
2013 Q2	$1.91M	Buy	+48,666	New	+$1.9M	0.04%	505

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Placemark Investments's TEVA Position: Q4 2014 in Review

Placemark Investments increased its Teva Pharmaceuticals (TEVA) stake by 5.1% in Q4 2014, buying an estimated $279K and bringing the position to 102,833 shares worth $5.91M. The position accounts for 0.1% of the portfolio, ranked #246.

Placemark Investments first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. 821 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

Placemark Investments held 102,833 shares of Teva Pharmaceuticals worth $5.91M as of Q4 2014.
Placemark Investments bought 4,999 Teva Pharmaceuticals shares in Q4 2014, an estimated $279K.
Teva Pharmaceuticals made up 0.1% of Placemark Investments's portfolio in Q4 2014, its #246 holding.
Placemark Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.